Skip to main content

Advertisement

SpringerLink
Log in

ASO Author Reflections: Return to Isolated Limb Infusion for In-Transit Melanoma

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. O’Donoghue C, Perez MC, Mullinax JE, et al. Isolated limb infusion: a single-center experience with over 200 infusions. Ann Surg Oncol. 2017;24:3842–9. https://doi.org/10.1245/s10434-017-6107-9.

    Article  PubMed  Google Scholar 

  2. Kroon HM, Moncrieff M, Kam PC, Thompson JF. Outcomes following isolated limb infusion for melanoma. A 14-year experience. Ann Surg Oncol. 2008;15:3003–13. https://doi.org/10.1245/s10434-008-9954-6.

    Article  PubMed  Google Scholar 

  3. Miura JT, Kroon HM, Beasley GM, et al. Long–term oncologic outcomes after isolated limb infusion for locoregionally metastatic melanoma: an international multicenter analysis. Ann Surg Oncol. 2019;26:2486–94. https://doi.org/10.1245/s10434-019-07288-w.

    Article  PubMed  Google Scholar 

  4. Carr MJ, Sun J, Kroon HM, et al. Oncologic outcomes after isolated limb infusion for advanced melanoma: an international comparison of the procedure and outcomes between the United States and Australia. Ann Surg Oncol. https://doi.org/10.1245/s10434-020-09051-y.

  5. Muilenburg, DJ, Beasley, GM, Thompson, ZJ, et al. Burden of disease predicts response to isolated limb infusion with melphalan and actinomycin D in melanoma. Ann Surg Oncol. 2015;22:482–8. https://doi.org/10.1245/s10434-014-4072-0.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cutaneous Oncology, Moffitt Cancer Center and Research Institute, Tampa, FL, USA

    Michael J. Carr MD, MS & Jonathan S. Zager MD

  2. Department of Surgery, Royal Adelaide Hospital, University of Adelaide, Adelaide, SA, Australia

    Hidde M. Kroon MD, PhD

  3. Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia

    Hidde M. Kroon MD, PhD

  4. Department of Oncological Sciences, University of South Florida Morsani College of Medicine, Tampa, FL, USA

    Jonathan S. Zager MD

Authors
  1. Michael J. Carr MD, MS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hidde M. Kroon MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jonathan S. Zager MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jonathan S. Zager MD.

Ethics declarations

Disclosures

Jonathan S. Zager has had a US patent issued (US Patent # 10,583,246) on high-flow ILI. Michael J. Carr and Hidde M. Kroon have no financial or material disclosures to report regarding the subject matter of this study and the discussion within this manuscript.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary file1 (PPTX 405 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Carr, M.J., Kroon, H.M. & Zager, J.S. ASO Author Reflections: Return to Isolated Limb Infusion for In-Transit Melanoma. Ann Surg Oncol 27, 5119–5120 (2020). https://doi.org/10.1245/s10434-020-09113-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-020-09113-1

Search

Navigation